Search research articles
Contact Us
Filters
Showing results (1-10 of 254) with videos related to
Page
of 26
Sort By:
Gastroenterology
|
July 26, 2011
Authorship: who should be included and how should it be determined?
Anna S Lok
The New England Journal of Medicine
|
May 28, 2026
A Major Step toward a Cure for Hepatitis B Infection
Anna S Lok
Seminars in Liver Disease
|
June 12, 2004
New treatment of chronic hepatitis B
Anna S Lok
Clinical and Molecular Hepatology
|
April 3, 2015
Personalized treatment of hepatitis B
Anna S Lok
Hepatology (Baltimore, Md.)
|
January 17, 2016
Reply
Anna S Lok
Hepatology (Baltimore, Md.)
|
February 18, 2010
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
Anna S Lok
Clinical Liver Disease
|
June 13, 2019
Issues in selecting HCV-infected candidates for anti-viral treatment
Anna S Lok
JAMA
|
December 1, 2024
Overcoming Hepatitis B Vaccine Nonresponsiveness
Ivan Hung, Anna S Lok
JAMA
|
November 9, 2023
Hepatitis D: A Review
Francesco Negro, Anna S Lok
Clinics in Liver Disease
|
July 4, 2019
Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials
Alisa Likhitsup, Anna S Lok
Page
of 26
Search research articles
Search
Showing results (1-10 of 254) with videos related to
Sort By:
Page
of 26
Gastroenterology
|
July 26, 2011
Authorship: who should be included and how should it be determined?
Anna S Lok
The New England Journal of Medicine
|
May 28, 2026
A Major Step toward a Cure for Hepatitis B Infection
Anna S Lok
Seminars in Liver Disease
|
June 12, 2004
New treatment of chronic hepatitis B
Anna S Lok
Clinical and Molecular Hepatology
|
April 3, 2015
Personalized treatment of hepatitis B
Anna S Lok
Hepatology (Baltimore, Md.)
|
January 17, 2016
Reply
Anna S Lok
Hepatology (Baltimore, Md.)
|
February 18, 2010
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
Anna S Lok
Clinical Liver Disease
|
June 13, 2019
Issues in selecting HCV-infected candidates for anti-viral treatment
Anna S Lok
JAMA
|
December 1, 2024
Overcoming Hepatitis B Vaccine Nonresponsiveness
Ivan Hung, Anna S Lok
JAMA
|
November 9, 2023
Hepatitis D: A Review
Francesco Negro, Anna S Lok
Clinics in Liver Disease
|
July 4, 2019
Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials
Alisa Likhitsup, Anna S Lok
Page
of 26